Results 51 to 60 of about 600,341 (272)

ChemBoost: A chemical language based approach for protein-ligand binding affinity prediction

open access: yes, 2020
Identification of high affinity drug-target interactions is a major research question in drug discovery. Proteins are generally represented by their structures or sequences.
Ozkirimli, Elif   +3 more
core   +1 more source

Enhanced information cross-attention fusion for drug–target binding affinity prediction [PDF]

open access: yesPeerJ Computer Science
Background The rapid development of artificial intelligence has permeated many fields, with its application in drug discovery becoming increasingly mature.
Ailu Fei   +5 more
doaj   +2 more sources

Structure based de novo design of IspD inhibitors as anti-tubercular agents [PDF]

open access: yes, 2012
Tuberculosis is one of the leading contagious diseases, caused by Mycobacterium tuberculosis. Despite improvements in anti-tubercular agents, it remains one of the most prevalent infectious diseases worldwide, responsible for a total of 1.6 million ...
Abhay T. Sangamwar   +4 more
core   +2 more sources

Affinity2Vec: drug-target binding affinity prediction through representation learning, graph mining, and machine learning

open access: yesScientific Reports, 2022
Drug-target interaction (DTI) prediction plays a crucial role in drug repositioning and virtual drug screening. Most DTI prediction methods cast the problem as a binary classification task to predict if interactions exist or as a regression task to ...
Maha A. Thafar   +5 more
doaj   +1 more source

BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology. [PDF]

open access: yes, 2015
BindingDB, www.bindingdb.org, is a publicly accessible database of experimental protein-small molecule interaction data. Its collection of over a million data entries derives primarily from scientific articles and, increasingly, US patents.
Baitaluk, Michael   +5 more
core   +1 more source

Selection Of A Novel Aptamer Against Vitronectin Using Capillary Electrophoresis And Next Generation Sequencing [PDF]

open access: yes, 2016
Breast cancer (BC) results in ≃40,000 deaths each year in the United States and even among survivors treatment of the disease may have devastating consequences, including increased risk for heart disease and cognitive impairment resulting from the toxic ...
Boyacioglu, O.   +8 more
core   +3 more sources

Discovering the Biological Target of 5-epi-Sinuleptolide Using a Combination of Proteomic Approaches

open access: yesMarine Drugs, 2017
Sinuleptolide and its congeners are diterpenes with a norcembranoid skeleton isolated from the soft coral genus Sinularia. These marine metabolites are endowed with relevant biological activities, mainly associated with cancer development.
Elva Morretta   +5 more
doaj   +1 more source

ELECTRA-DTA: a new compound-protein binding affinity prediction model based on the contextualized sequence encoding

open access: yesJournal of Cheminformatics, 2022
Motivation Drug-target binding affinity (DTA) reflects the strength of the drug-target interaction; therefore, predicting the DTA can considerably benefit drug discovery by narrowing the search space and pruning drug-target (DT) pairs with low binding ...
Junjie Wang   +4 more
doaj   +1 more source

The efficiency of multi-target drugs: the network approach might help drug design

open access: yes, 2005
Despite considerable progress in genome- and proteome-based high-throughput screening methods and rational drug design, the number of successful single target drugs did not increase appreciably during the past decade.
Agoston, Vilmos   +2 more
core   +1 more source

QSAR studies on Withanolide analogs for anticancer activity [PDF]

open access: yes, 2011
Withanolides are a group of pharmacologically active compounds present in most prodigal amounts in roots and leaves of Withania somnifera (Indian ginseng), one of the most important medicinal plants of Indian systems of medicine.
Dharmendra Kumar Yadav   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy